ANG1 activation of TIE2 promotes stabilization of vessels, while ANG2, a context-dependent mild TIE2 agonist/antagonist, enhances abnormal tumor angiogenesis, permeability of vessels, and inflammation. The gene discussed is TEK; the disease is neoplasm.